Evidence map›Paper›PMID 35980408›Full record

ReviewThe western journal of emergency medicine2022

Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment.

Brian M Clemency, Rachel A Hoopsick, Susan J Burnett, Linda S Kahn, Joshua J Lynch

Open access · goldAbstract readReview
In one paragraph

Review in The western journal of emergency medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Brian M ClemencyThe University at Buffalo, Department of Emergency Medicine, Buffalo, New York.
Rachel A HoopsickUniversity of Illinois Urbana-Champaign, Department of Kinesiology and Community Health, Urbana, Illinois.
Susan J BurnettThe University at Buffalo, Department of Emergency Medicine, Buffalo, New York.
Linda S KahnThe University at Buffalo, Department of Family Medicine, Buffalo, New York.
Joshua J LynchThe University at Buffalo, Department of Emergency Medicine, Buffalo, New York.
National Hospital for Neurology and Neurosurgery · GBJacobs Institute · USUniversity College London · GBUniversity of Illinois Urbana-Champaign · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
UB Clinical Scholar Program in Implementation Science to Achieve Triple AimsK12HL138052 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CANTY, JOHN M, SINGH, RANJIT · 2017 to 2021
$3.1M
NCATS NIH HHS UL1 TR001412NHLBI NIH HHS K12 HL138052
6 · The paper itself

Abstract

introductionMedications for opioid use disorder (MOUD), including buprenorphine, represent an evidence-based treatment that supports long-term recovery and reduces risk of overdose death. Patients in crisis from opioid use disorder (OUD) often seek care from emergency departments (ED). The New York Medication for Addiction Treatment and Electronic Referrals (MATTERS) network is designed to support ED-initiated buprenorphine and urgent referrals to long-term care for patients suffering from OUD.

methodsUsing the PRECEDE-PROCEED implementation science framework, we provide an overview of the creation of the MATTERS network in Western New York. We also include an explanation of how the network was designed and launched as a response to the opioid epidemic. Finally, we analyzed the program's outputs and outcomes, thus far, as it continues to grow across the state.

resultsThe New York MATTERS network was created and implemented in 2019 with a single hospital referring patients with OUD to three local clinics. In the social assessment and situational analysis phase, we describe the opioid epidemic and available resources in the region at the outset of the program. In the epidemiological assessment phase, we quantify the epidemic on the state and regional levels. In the educational and ecological assessment, we review local ED practices and resources. In the administrative and policy assessment and intervention alignment phase, the program's unique framework is reviewed. In the piloting phase, we describe the initial deployment of New York MATTERS. Finally, in the process evaluation phase, we depict the early lessons we learned. By the beginning of 2021, the New York MATTERS network included 35 hospitals that refer to 47 clinics throughout New York State.

conclusionThe New York MATTERS network provides a structured approach to reduce barriers to ED-initiated buprenorphine and urgent referral to long-term care. An implementation framework provides a structured means of evaluating this best practice model.

Indexed as

BuprenorphineOpioid-Related DisordersAnalgesics, OpioidEmergency Service, HospitalHumansNarcotic AntagonistsOpiate Substitution TreatmentAnalgesics, OpioidBuprenorphineNarcotic Antagonists

Identifiers

PMID35980408
PMCPMC9391018
OpenAlexW4288057311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.